Newsletter
Earnings
Interviews
Transcripts
×
Menu
Home
Earnings
Interviews
Transcripts
IPO
Tech
pharmaceuticals
Transcript
Jazz Pharmaceuticals PLC (JAZZ) Q3 2022 Earnings Call Transcript
November 10, 2022
Transcript
Perrigo Co PLC (PRGO) Q3 2022 Earnings Call Transcript
November 10, 2022
Earnings: Trxade Health (MEDS) reports 6% drop in Q3 revenue; loss narrows
November 8, 2022
Transcript
Zoetis Inc (ZTS) Q3 2022 Earnings Call Transcript
November 4, 2022
Consider these factors before investing in Eli Lilly and Company (LLY)
November 2, 2022
Transcript
Eli Lilly and Company (LLY) Q3 2022 Earnings Call Transcript
November 2, 2022
Four noteworthy points from Pfizer’s (PFE) Q3 2022 earnings report
November 1, 2022
Earnings: Highlights of Eli Lilly’s (LLY) Q3 2022 results
November 1, 2022
Pfizer (PFE) Q3 2022 Earnings: Key financials and quarterly highlights
November 1, 2022
ABBV Infographic: AbbVie’s Q3 earnings beat estimates; revenue up 3%
October 28, 2022
Infographic: Highlights of Merck’s (MRK) Q3 2022 earnings
October 27, 2022
BIIB Stock: Is Biogen an investment worth trying now?
October 26, 2022
Infographic: Highlights from Biogen’s (BIIB) Q3 2022 earnings results
October 25, 2022
Infographic: Highlights of Intuitive Surgical’s Q3 2022 earnings
October 19, 2022
Key highlights from Abbott (ABT) Q3 2022 earnings results
October 19, 2022
JNJ Earnings: Johnson & Johnson Q3 adj. profit drops despite higher sales
October 18, 2022
Johnson & Johnson (JNJ) offers long-term stability. Is the stock a buy?
October 11, 2022
TLRY Earnings: Highlights of Tilray’s Q1 2023 financial results
October 10, 2022
ANGO Earnings: AngioDynamics Q1 loss widens. Revenue up 6%
October 7, 2022
Prime Medicine is the next big biotech to pursue IPO. Here’s all you need to know
September 27, 2022
Trxade Health Inc. (NASDAQ: MEDS) Q3 2022 Research Summary
September 7, 2022
Posts pagination
« Previous
1
…
14
15
16
17
18
…
34
Next »
Top